Skip to main content
Third Circuit· 10/27/2022

Liquid Labs LLC v. FDA

Citations

  • 52 F.4th 533

How courts have described this case

Verbatim parenthetical descriptions written by other courts when citing this decision. Ranked by citation-network relevance.

  • finding that “the statute and June 2019 Guidance are clear about comparative analysis”
  • upholding the FDA’s denial of approval to market an open- system e-liquid because flavors appealed to children regardless of the device type
  • “[T]he FDA did not “reverse course” and newly require randomized controlled trials and/or longitudinal cohort studies, and therefore did not upset Liquid Labs’ reliance interests, provide inadequate notice, or act arbitrarily and capriciously.”

Source: CourtListener parenthetical corpus (CC0).

Read full opinion on CourtListener

Cited by

9 cases in this archive cite this case.

Cites

15 cases in this archive are cited by this case.

Sourced from CourtListener / Free Law Project (CC0).

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.